Mitsubishi UFJ Asset Management (UK)’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Buy
18,000
+5,000
+38% +$390K 0.72% 49
2025
Q4
$1.03M Buy
13,000
+5,000
+63% +$433K 0.5% 58
2025
Q3
$733K Buy
8,000
+3,000
+60% +$245K 0.35% 72
2025
Q2
$326K Hold
5,000
0.17% 95
2025
Q1
$335K Buy
+5,000
New +$299K 0.18% 93
2024
Q3
Sell
-4,000
Closed -$255K 115
2024
Q2
$255K Hold
4,000
0.13% 95
2024
Q1
$277K Hold
4,000
0.14% 97
2023
Q4
$221K Sell
4,000
-6,000
-60% -$330K 0.12% 82
2023
Q3
$581K Sell
10,000
-5,000
-33% -$289K 0.41% 79
2023
Q2
$807K Hold
15,000
0.52% 62
2023
Q1
$596K Sell
15,000
-8,000
-35% -$337K 0.39% 79
2022
Q4
$925K Hold
23,000
0.65% 54
2022
Q3
$739K Hold
23,000
0.57% 59
2022
Q2
$682K Hold
23,000
0.39% 68
2022
Q1
$647K Buy
23,000
+7,000
+44% +$261K 0.29% 84
2021
Q4
$737K Hold
16,000
0.31% 77
2021
Q3
$525K Buy
+16,000
New +$497K 0.22% 83
2019
Q4
Sell
-13,000
Closed -$947K 80
2019
Q3
$947K Hold
13,000
0.44% 59
2019
Q2
$1.07K Buy
+13,000
New +$925K 0.01% 62

Other funds holding ANIP